Your browser doesn't support javascript.
Coronavirus Disease 2019 (COVID-19) Mitigation Efforts and Testing During an In-Person Training Event-Uganda, 12-29 October 2020.
Laws, Rebecca L; Biraro, Sam; Kirungi, Wilford; Gianetti, Brittany; Aibo, Dorothy; Awor, Anna C; West, Christine; Sachathep, Karampreet K; Kiyingi, Herbert; Ward, Jennifer; Mwangi, Christina; Nkurunziza, Peter; Okimait, David; Currie, Dustin; Ajiboye, Aderonke; Moore, Carole S; Patel, Hetal; Sendagala, Sam; Naluguza, Mary; Mugisha, Veronicah; Low, Andrea; Delgado, Stephen; Hoos, David; Brown, Kristin; Galbraith, Jennifer S; Hladik, Wolfgang; Nelson, Lisa; El-Sadr, Wafaa; Musinguzi, Joshua; Voetsch, Andrew C.
  • Laws RL; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Biraro S; ICAP at Columbia University, Kampala, Uganda.
  • Kirungi W; Uganda Ministry of Health, Kampala, Uganda.
  • Gianetti B; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Aibo D; ICAP at Columbia University, Kampala, Uganda.
  • Awor AC; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • West C; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Sachathep KK; ICAP at Columbia University, New York, New York, USA.
  • Kiyingi H; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Ward J; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Mwangi C; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Nkurunziza P; ICAP at Columbia University, Kampala, Uganda.
  • Okimait D; ICAP at Columbia University, Kampala, Uganda.
  • Currie D; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Ajiboye A; Epidemic Intelligence Service, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Moore CS; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Patel H; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Sendagala S; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Naluguza M; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Mugisha V; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Low A; ICAP at Columbia University, New York, New York, USA.
  • Delgado S; ICAP at Columbia University, New York, New York, USA.
  • Hoos D; ICAP at Columbia University, New York, New York, USA.
  • Brown K; ICAP at Columbia University, New York, New York, USA.
  • Galbraith JS; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Hladik W; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Nelson L; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • El-Sadr W; Division of Global HIV and TB, Centers for Disease Control and Prevention, Kampala, Uganda.
  • Musinguzi J; ICAP at Columbia University, New York, New York, USA.
  • Voetsch AC; Uganda Ministry of Health, Kampala, Uganda.
Clin Infect Dis ; 73(Suppl 1): S42-S44, 2021 07 15.
Article in English | MEDLINE | ID: covidwho-1364772
ABSTRACT
Large public-health training events may result in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission. Universal SARS-CoV-2 testing during trainings for the Uganda Population-based HIV Impact Assessment identified 28 of 475 (5.9%) individuals with coronavirus disease 2019 (COVID-19) among attendees; most (89.3%) were asymptomatic. Until COVID-19 vaccine is readily available for staff and participants, effective COVID-19 mitigation measures, along with SARS-CoV-2 testing, are recommended for in-person trainings, particularly when trainees will have subsequent contact with survey participants.
Subject(s)
Keywords
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Observational study Topics: Vaccines Limits: Humans Country/Region as subject: Africa Language: English Journal: Clin Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: Cid